TRex Bio Reports Third Quarter Financial Results
TRex Bio, Inc. has released its third-quarter financial results, reporting a net loss of $13.2 million. This represents an increase in losses compared to the $7.9 million reported during the same period in the previous year. As of September 30, 2026, the company held $78.2 million in cash, cash equivalents, and marketable securities. This liquidity position excludes approximately $119.0 million in net proceeds generated from its initial public offering.
Tickers: $TRXB
Topics: cash position financial results net loss